MCID: AGN002
MIFTS: 56

Agnosia malady

Categories: Rare diseases, Mental diseases, Eye diseases

Aliases & Classifications for Agnosia

About this section

Aliases & Descriptions for Agnosia:

Name: Agnosia 11 46 47 13 25 37 66
Primary Visual Agnosia 46 66
Dyspraxia 11 47
Apraxias 37 66
 
Monomodal Visual Amnesia 46
Dyspraxia Syndrome 11
Visual Amnesia 46
Alexia 66

Classifications:



Summaries for Agnosia

About this section
NIH Rare Diseases:46 Agnosia is characterized by an inability to recognize and identify objects and/or persons. symptoms may vary, according to the area of the brain that is affected. it can be limited to one sensory modality such as vision or hearing; for example, a person may have difficulty in recognizing an object as a cup or identifying a sound as a cough. agnosia can result from strokes, traumatic brain injury, dementia, a tumor, developmental disorders, overexposure to environmental toxins (e.g., carbon monoxide poisoning), or other neurological conditions. visual agnosia may also occur in association with other underlying disorders. people with agnosia may retain their cognitive abilities in other areas. treatment of primary agnosia is symptomatic and supportive; when it is caused by an underlying disorder, treatment of the disorder may reduce symptoms and help prevent further brain damage. last updated: 4/22/2011

MalaCards based summary: Agnosia, also known as primary visual agnosia, is related to semantic agnosia and visual agnosia, and has symptoms including cachexia, cyanosis and dyspnea. An important gene associated with Agnosia is OPRM1 (Opioid Receptor Mu 1), and among its related pathways are Syndecan-3-mediated signaling events and Peptide ligand-binding receptors. Affiliated tissues include brain, parietal lobe and temporal lobe, and related mouse phenotypes are adipose tissue and integument.

Disease Ontology:11 A communication disorder that is a loss of ability to recognize objects, persons, sounds, shapes, or smells while the specific sense is not defective nor is there any significant memory loss.

NINDS:47 Agnosia is a rare disorder characterized by an inability to recognize and identify objects or persons. People with agnosia may have difficulty recognizing the geometric features of an object or face or may be able to perceive the geometric features but not know what the object is used for or whether a face is familiar or not. Agnosia can be limited to one sensory modality such as vision or hearing. For example, a person may have difficulty in recognizing an object as a cup or identifying a sound as a cough. Agnosia can result from strokes, dementia, developmental disorders, or other neurological conditions. It typically results from damage to specific brain areas in the occipital or parietal lobes of the brain. People with agnosia may retain their cognitive abilities in other areas.

Wikipedia:69 Agnosia is the inability to process sensory information. Often there is a loss of ability to recognize... more...

Related Diseases for Agnosia

About this section

Diseases in the Agnosia family:

Form Agnosia

Diseases related to Agnosia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 98)
idRelated DiseaseScoreTop Affiliating Genes
1semantic agnosia28.3AP1M2, AP2M1, CCK, CNR1, HTR7, NPFF
2visual agnosia12.2
3auditory agnosia12.2
4rolandic epilepsy, mental retardation, and speech dyspraxia12.2
5developmental dyspraxia12.2
6tactile agnosia12.1
7form agnosia12.1
8topographical agnosia12.1
9apperceptive agnosia12.1
10verbal auditory agnosia12.1
11finger agnosia12.1
12associative agnosia12.1
13pain agnosia12.1
14integrative agnosia12.1
15mirror agnosia12.0
16visual verbal agnosia12.0
17social emotional agnosia12.0
18time agnosia12.0
19color agnosia11.9
20rolandic epilepsy-speech dyspraxia syndrome11.9
21astereognosia11.4
22autotopagnosia11.2
23prosopagnosia10.7
24lymphocytic hypophysitis10.7CNR1, TRPV1
25pediatric mesenchymal chondrosarcoma10.7PDYN, POMC
26spastic paraplegia 46, autosomal recessive10.7APTX, SETX
27apraxia10.7
28alexia10.7
29morphine dependence10.7OPRM1, PDYN, POMC
30transient global amnesia10.6PDYN, PSENEN
31necatoriasis10.6APTX, PDYN, SETX
32cortical deafness10.6
33cocaine dependence10.6CNR1, OPRM1, POMC
34ureter adenocarcinoma10.6CCK, PDYN
35focal hand dystonia10.5OXT, TAC1
36malt worker's lung10.5CCK, TAC1
37lymphosarcoma10.5CCK, CNR1, POMC
38muscular dystrophy, limb-girdle, type 2c10.5APTX, SETX
39hydrophthalmos10.5OPRM1, PDYN
40corneal dystrophy10.5CCK, OPRM1
41vulvar melanoma10.5CCK, OPRM1, TAC1
42gerstmann syndrome10.4
43pericoronitis10.4PDYN, POMC
44alexithymia10.4
45amusia10.4
46anosognosia10.4
47agraphia10.4
48transsexualism10.4CNR1, HTR7, PDYN, POMC
49aphasia10.4
50achromatopsia10.3

Graphical network of the top 20 diseases related to Agnosia:



Diseases related to agnosia

Symptoms for Agnosia

About this section

UMLS symptoms related to Agnosia:


cachexia, cyanosis, dyspnea, enuresis, headache, seizures, signs and symptoms, signs and symptoms, digestive, syncope, vertigo, hallucinations, olfactory, disturbance of consciousness, visual agnosia, other and unspecified symbolic dysfunctions, dyslexia and other symbolic dysfunctions, not elsewhere classified, specific learning problem, hot flushes, neurologic neglect syndrome, cortical dysfunction nec, hemiapraxia, amimia, symptoms, autoscopy, altered pitch perception, hemiasomatognosia, scanning speech, alexia and agraphia present, lethargy, muscle rigidity, torticollis, clumsiness, extrapyramidal sign, other and unspecified lack of coordination, neurological symptom/complaint other, abnormal coordination, dyspraxia of arm, neurobehavioral manifestations, gait dyspraxia

Drugs & Therapeutics for Agnosia

About this section

Drugs for Agnosia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
OxytocinPhase 039050-56-6439302, 53477758
Synonyms:
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
(Arg8)-Vasopressin
(Arg8)-Vasotocin
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
50-56-6
AC1L9735
Argipressin
Argpressin Acetate
BCBcMAP01_000094
Biotinyl-(Arg8)-Vasopressin
C00746
CHEBI:492195
CHEBI:7872
CHEMBL395429
CID439302
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
D00089
Disulfide bridge Cys1-Cys6
Gly-Leu-Pro-c
HS-2021
 
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
MolPort-003-938-941
NCGC00167132-01
O3251_SIGMA
O4375_SIGMA
OXT
OXYTOCIN
Ocytocin
Oxitocina
Oxytocic hormone
Oxytocin (JP15/USP/INN)
Oxytocin (TN)
Oxytocin 10 Usp Units In Dextrose 5%
Oxytocin 20 Usp Units In Dextrose 5%
Oxytocin 5 Usp Units In Dextrose 5%
Oxytocin Acetate
Oxytocin injection
Oxytocine
Oxytocinum
Pitocin
Pitocin (TN)
Syntocinon
Syntocinon (TN)
TI-001
alpha-Hypophamine
nchembio.184-comp2

Interventional clinical trials:

idNameStatusNCT IDPhase
1Orientation Agnosia: Clinical and Anatomical StudyCompletedNCT01304576
2Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)CompletedNCT00908999
3Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study for People With Parkinson'sRecruitingNCT02561715
4Anosognosia Evaluation After Cranocerebral Trauma Moderate to SevereRecruitingNCT02333006
5Processing Integration in Neurological Patients Using fMRINot yet recruitingNCT02722070
6Perception and Multisensory Integration in Neurological Patients Using fMRINot yet recruitingNCT01469858
7The Effect of Oxytocin on Face PerceptionSuspendedNCT02091817Phase 0

Search NIH Clinical Center for Agnosia


Cochrane evidence based reviews: apraxias

Genetic Tests for Agnosia

About this section

Genetic tests related to Agnosia:

id Genetic test Affiliating Genes
1 Agnosia25

Anatomical Context for Agnosia

About this section

MalaCards organs/tissues related to Agnosia:

34
Brain, Parietal lobe, Temporal lobe, Cortex, Eye, Testes, T cells

Animal Models for Agnosia or affiliated genes

About this section

MGI Mouse Phenotypes related to Agnosia:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053759.5CNR1, OPRM1, OXT, PDYN, POMC, TRPV1
2MP:00107718.8CNR1, HTR7, OPRL1, OPRM1, OXT, PDYN
3MP:00053768.0AP1M2, APTX, CCK, CNR1, HTR7, OPRL1
4MP:00053867.7CCK, CNR1, HTR7, OPRL1, OPRM1, OXT

Publications for Agnosia

About this section

Articles related to Agnosia:

(show top 50)    (show all 403)
idTitleAuthorsYear
1
Agnosia for head tremor in essential tremor: prevalence and clinical correlates. (26877883)
2016
2
Affective agnosia: Expansion of the alexithymia construct and a new opportunity to integrate and extend Freud's legacy. (26054794)
2015
3
Simultanagnosia and scene agnosia induced by right posterior cerebral artery infarction: a case report. (26369377)
2015
4
Functional Mapping of the Human Auditory Cortex: fMRI Investigation of a Patient with Auditory Agnosia from Trauma to the Inferior Colliculus. (26413744)
2015
5
Reprint of: Visual processing of words in a patient with visual form agnosia: A behavioural and fMRI study. (26475097)
2015
6
Corticobasal syndrome presenting with partial Gerstmann's syndrome and digit agnosia. (23686076)
2013
7
Eye movements during object recognition in visual agnosia. (22627025)
2012
8
Development of a vocabulary of object shapes in a child with a very-early-acquired visual agnosia: a unique case. (20680887)
2011
9
Preserved implicit form perception and orientation adaptation in visual form agnosia. (16620887)
2006
10
Covert colour processing in colour agnosia. (16420956)
2006
11
A 3-year follow-up study of 'orientation agnosia'. (15817180)
2005
12
A Case Study of Visual Agnosia without Perceptual Processing or Structural Descriptions Impairment. (20957586)
2003
13
The role of premorbid expertise on object identification in a patient with category-specific visual agnosia. (20957546)
2002
14
Superior single dimension relative to "exclusive or" categorization performance by a patient with category-specific visual agnosia: empirical data and an ALCOVE simulation. (10857684)
2000
15
Perception of dynamic acoustic patterns by an individual with unilateral verbal auditory agnosia. (10860565)
2000
16
Number processing and calculation in a case of visual agnosia. (10921666)
2000
17
Auditory agnosia restricted to environmental sounds following cortical deafness and generalized auditory agnosia. (10996714)
2000
18
Impaired face and word recognition without object agnosia. (9920470)
1999
19
Grasping spatial relationships: failure to demonstrate allocentric visual coding in a patient with visual form agnosia. (9787053)
1998
20
Separate visual pathways for perception of actions and objects: evidence from a case of apperceptive agnosia. (9728957)
1998
21
Chronic auditory agnosia following Landau-Kleffner syndrome: a 23 year outcome study. (9672766)
1998
22
Agnosia for object orientation: implications for theories of object recognition. (9025119)
1997
23
Literature update. Agnosia in Alzheimer disease. (9305505)
1997
24
Visual form agnosia in multiple sclerosis. (8874592)
1996
25
A comment on apperceptive agnosia. (7546671)
1995
26
Capgras syndrome: agnosia of identification and delusion of reduplication. (7846236)
1994
27
Visual agnosia: a case of reduced attentional "spotlight"? (1478087)
1992
28
Selective loss of imagery in a case of visual agnosia. (1528412)
1992
29
The role of sensorimotor experience in object recognition. A case of multimodal agnosia. (1782531)
1991
30
A case of integrative visual agnosia. (3427396)
1987
31
Loss of topographic familiarity. An environmental agnosia. (3947250)
1986
32
Correlation between EEG and auditory perceptual measures in auditory agnosia. (6722527)
1984
33
Taste agnosia following gustatory neocortex ablation: dissociation from odor and generality across taste qualities. (6540588)
1984
34
Auditory agnosia. (6125975)
1982
35
Distinctive features of unilateral spatial agnosia in right and left brain-damaged patients. (615703)
1977
36
A visual-speech disconnexion syndrome. Report of a case with optic aphasia, agnosic alexia and colour agnosia. (4773861)
1973
37
Generalized auditory agnosia: the first phase of treatment. (5027354)
1972
38
Right-sided unilateral visual spatial agnosia, asomatognosia and anosognosia with left hemisphere lesions. (5806126)
1969
39
PURE AUDITORY AGNOSIA ASSOCIATED WITH ALTERATION OF VOICE AND PERSONAL CHARACTER. A CASE REPORT. (14332144)
1965
40
OBSERVATIONS ON COLOUR AGNOSIA. (14200783)
1964
41
Clumsy children: developmental apraxia and agnosia. (13998739)
1962
42
Agnosia for faces (prosopagnosia). (13905818)
1962
43
An analysis of agnosia. (13165875)
1954
44
Visual agnosia and alternating dominance; analysis of a case. (13109456)
1953
45
Visual agnosia for animate objects. (13085184)
1953
46
Cerebral localization in aphasia and agnosia. (14770629)
1950
47
Visual-spatial agnosia associated with lesions of the right cerebral hemisphere. (14791786)
1950
48
Pure visual verbal agnosia with spatial disorientation; report of a case. (18910047)
1948
49
Unilateral auditory-spatial agnosia. (18879812)
1948
50
Aphasia, apraxia, and agnosia; a new classification. (21017997)
1946

Variations for Agnosia

About this section

Expression for genes affiliated with Agnosia

About this section
Search GEO for disease gene expression data for Agnosia.

Pathways for genes affiliated with Agnosia

About this section

GO Terms for genes affiliated with Agnosia

About this section

Cellular components related to Agnosia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1postsynapseGO:009879410.6NPFF, OPRM1
2perikaryonGO:004320410.0CCK, NPFF, OPRM1
3axon terminusGO:00436799.9NPFF, PDYN, PNOC
4axonGO:00304249.7CCK, CNR1, SETX, TAC1
5dendriteGO:00304259.4CCK, NPFF, OPRM1, PDYN, PNOC, TRPV1
6terminal boutonGO:00431959.3AP2M1, CCK, OXT
7neuronal cell bodyGO:00430259.3CCK, PDYN, PNOC, TAC1, TRPV1
8plasma membraneGO:00058867.8AP2M1, CNR1, HTR7, OPRL1, OPRM1, PDYN

Biological processes related to Agnosia according to GeneCards Suite gene sharing:

(show all 24)
idNameGO IDScoreTop Affiliating Genes
1opioid receptor signaling pathwayGO:003800310.8OPRL1, OPRM1
2positive regulation of gastric acid secretionGO:006045410.7OPRL1, TRPV1
3estrous cycleGO:004484910.6OPRL1, OPRM1
4negative regulation of appetiteGO:003209910.5CCK, NPFF
5negative regulation of heart rateGO:001045910.5NPFF, TAC1
6positive regulation of ossificationGO:004577810.5OXT, TAC1
7acute inflammatory response to antigenic stimulusGO:000243810.5NPFF, OPRM1
8response to painGO:004826510.4TAC1, TRPV1
9response to foodGO:003209410.4OPRM1, OXT
10sensory perceptionGO:000760010.3OPRL1, OPRM1, PDYN, PNOC
11positive regulation of blood pressureGO:004577710.2CNR1, NPFF, OXT
12G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerGO:000718710.2CNR1, HTR7, OPRM1
13eating behaviorGO:004275510.1CCK, OPRL1, OPRM1, OXT
14negative regulation of cAMP biosynthetic processGO:003081810.1OPRL1, OPRM1
15positive regulation of renal sodium excretionGO:003581510.1OXT, TAC1
16positive regulation of apoptotic processGO:004306510.0CCK, CNR1, PSENEN, TRPV1
17regulation of sensory perception of painGO:00519309.9CCK, NPFF, OPRL1, OPRM1, OXT
18sensory perception of painGO:00192339.8CNR1, OPRL1, OPRM1, TAC1, TRPV1
19response to cocaineGO:00422209.8CNR1, OPRM1, OXT
20positive regulation of cytosolic calcium ion concentrationGO:00072049.7NPFF, OPRL1, OXT, TAC1, TRPV1
21response to morphineGO:00432789.6CNR1, NPFF, OPRM1, TAC1
22negative regulation of blood pressureGO:00457769.5CNR1, OPRL1, OXT
23neuropeptide signaling pathwayGO:00072189.5NPFF, OPRL1, OPRM1, PDYN, PNOC, POMC
24chemical synaptic transmissionGO:00072688.9HTR7, NPFF, OPRL1, OPRM1, PDYN, PNOC

Molecular functions related to Agnosia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1neuropeptide bindingGO:004292310.5OPRL1, OPRM1
2opioid receptor bindingGO:003162810.3PDYN, PNOC
3opioid peptide activityGO:000151510.0PDYN, PNOC
4neuropeptide hormone activityGO:00051849.2CCK, NPFF, OXT, PDYN, PNOC, POMC

Sources for Agnosia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet